PUT/INTUITIVE SURGICAL/200/0.01/19.07.24 Stock

Warrant

DE000GG51TN5

Real-time BOERSE MUENCHEN 03:05:45 2024-07-03 EDT
0.001 EUR 0.00% Intraday chart for PUT/INTUITIVE SURGICAL/200/0.01/19.07.24
3 months-75.00%
Date Price Change
24-07-03 0.001 0.00%
24-07-02 0.001 0.00%
24-07-01 0.001 0.00%
24-06-28 0.001 0.00%
24-06-27 0.001 0.00%

Real-time BOERSE MUENCHEN

Last update July 03, 2024 at 03:05 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer Goldman Sachs
WKN GG51TN
ISINDE000GG51TN5
Date issued 2024-03-08
Strike 200 $
Maturity 2024-07-19 (17 Days)
Parity 100 : 1
Emission price 0.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.007
Lowest since issue 0.001
Delta-0.02x
Omega 5.976
Premium54.69x
Gearing371.22x
Moneyness 0.4558
Difference Strike -238.8 $
Difference Strike %-119.41%
Spread 0.02
Spread %95.24%
Theoretical value 0.0360
Implied Volatility 243.33 %
Total Loss Probability 90.19 %
Intrinsic value 0.000000
Present value 0.0360
Break even 196.13 €
Theta-0.03x
Vega0x
Rho-0x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
438.8 USD
Average target price
428.1 USD
Spread / Average Target
-2.44%
Consensus